Case will be performed at Baptist Health, Jacksonville, Florida, by Dr Matthew McKillop, MD, and Dr Aaditya Vora, MD
Case session, co-sponsored by Abbott, will also feature EnSiteX™ LiveSync™ data streaming
London, 4th February 2026: RHYTHM AI Ltd (“RHYTHM AI” or “the Company”), a UK company focused on optimizing atrial fibrillation (AF) procedures, announces that its lead product, STAR Apollo™ Mapping System, will be featured during a live case transmission at the 31st Annual International AF Symposium in Boston, MA on February 6th 2026.
The AF mapping and ablation procedure will be carried out using the STAR Apollo Mapping System and Abbott’s EnSiteX™ 3D Mapping System with LiveSync™ data streaming. STAR Apollo optimizes AF procedures with real time analysis of data from the LiveSync data transfer function of EnSiteX. STAR Apollo uses advanced AI driven algorithms to show repeating patterns of activation within the atria and identify regions of the heart that are potential drivers of AF. This allows the physician to create a customized treatment plan for each specific patient. STAR Apollo received FDA clearance for use with EnSiteX LiveSync in September 2024.
The live case transmission will be performed by Dr Matthew McKillop, Clinical Cardiac Electrophysiologist and Medical Director, Electrophysiology Program, and Dr Aaditya Vora, Clinical Cardiac Electrophysiologist and Medical Director, Heart Specialist, at Baptist Health, Jacksonville, Florida. It will take place at 10.30 am EST on Friday, February 6th 2026 during the Case Transmissions Session 4 of the symposium. The three-day symposium brings together the world’s leading medical scientists to share the most recent advances in the field of AF.
Dr Matthew McKillop, MD, FACC, FHRS, Clinical Cardiac Electrophysiologist and Medical Director, Electrophysiology Program, Baptist Health, Jacksonville, Florida commented: “STAR Apollo mapping identifies sources of atrial fibrillation in the left and right atria which allow us to build targeted and tailored ablation treatment strategies for patients with recurrent atrial fibrillation after pulmonary vein isolation. Gone are the days, I believe, for empiric/anatomic ablation beyond pulmonary vein isolation. Atrial fibrillation ablation, like all other forms of arrhythmia, is a mapping guided enterprise and this will lead us to increasingly better patient outcomes.”
Prof Richard Schilling, Chairman and Co Founder of RHYTHM AI, commented: “The challenge of delivering AF ablation safely has now been largely solved by pulsed field ablation (PFA). The next frontier is to answer where best to deliver ablation. We believe STAR Apollo mapping addresses this using basic electrophysiology principles to assist the physician in deciding which areas to deliver ablation in order to give the patient the best possible outcome.”